Morepen Q2 profit rises 273% as H1 EBITDA margin reaches 16.5%

Management guided margin improvementOrder pipeline disclosedInvestor Communications View source PDF Explain this filing

MOREPENLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.6%Reaction day

₹126.51

prior close

₹132.31

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.7%+2.9% vs market

Pharmaceuticals peers, median of 173sector+2.0%+2.6% vs sector

On the reaction day the stock moved 2.9 pts more than Nifty Microcap 250 and 2.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.6+1.7+2.9+2.0+2.6

Next day

-0.7+1.8-2.5+2.6-3.4

-5.7+2.5-8.2+2.7-8.4

-10.4-0.1-10.3+2.0-12.4

-14.9+1.4-16.2+2.1-17.0

-19.1+1.6-20.7+2.2-21.4

-23.9+5.0-28.9+3.9-27.8

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Morepen posted a second consecutive quarter of record revenue and earnings. Q2 FY27 revenue rose 17.45% to Rs 755 crore, EBITDA rose 81% to Rs 132 crore and profit after tax rose 273% to Rs 89 crore. H1 revenue rose 57% to Rs 1,330 crore; EBITDA rose 243% to Rs 220 crore and margin reached 16.5%. Contract manufacturing revenue reached Rs 825 crore, exports rose 122% to Rs 654 crore, and management cited a wider customer pipeline.

Likely market impact

Strong earnings, wider margins and contract manufacturing scale-up are positive for the stock, though capacity expansion adds execution risk.